|
|
Article: Study results from Mayo Clinic update understanding of hepatitis C virus.
- Article from:
- Hepatitis Weekly
- Article date:
- November 16, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to a study from the United States, "Many patients with chronic hepatitis C have not responded to therapy with pegylated interferon plus ribavirin. To evaluate use of peginterferon-alpha 2a plus ribavirin to re-treat nonresponders to peginterferon-alpha 2b plus ribavirin."
"Randomized, parallel-group trial conducted between September 2003 and February 2007. and researchers were not blinded to intervention assignment. Random assignment was centralized, computer-generated, and stratified by geographic region, hepatitis C virus (HCV) genotype, and histologic diagnosis. 106 international centers. 950 nonresponders to 12 or more weeks of therapy with ...